{"preliminary_commentary":{"by_channel":{"x_thread":12,"youtube":1},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT02468024\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"name":"STABLE-MATES","nct_id":"NCT02468024","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=stable-mates-nct02468024. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"STABLE-MATES","arms":[{"description":"Sublobar Resection (SR)","label":"Arm 1 lung surgery","type":"ACTIVE_COMPARATOR"},{"description":"Stereotactic Ablative Radiotherapy (SAbR)","label":"Arm 2 radiation therapy","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2028-12","type":"ESTIMATED"},"conditions":["Non-Small Cell Lung Cancer"],"enrollment":{"count":272,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Lung Surgery","otherNames":["SR"],"type":"PROCEDURE"},{"name":"Radiation therapy","otherNames":["SAbR"],"type":"RADIATION"}],"last_update":"2026-04-16","lead_sponsor":"University of Texas Southwestern Medical Center","official_title":"JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial","overall_status":"RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2028-12","type":"ESTIMATED"},"primary_outcomes":[{"measure":"overall survival","timeFrame":"3 years"}],"references":[{"citation":"Elbanna M, Shiue K, Edwards D, Cerra-Franco A, Agrawal N, Hinton J, Mereniuk T, Huang C, Ryan JL, Smith J, Aaron VD, Burney H, Zang Y, Holmes J, Langer M, Zellars R, Lautenschlaeger T. Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy. Clin Lung Cancer. 2021 May;22(3):e342-e359. doi: 10.1016/j.cllc.2020.05.024. Epub 2020 Jun 2.","pmid":"32736936","type":"DERIVED"}],"start_date":{"date":"2015-07","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer","url":"https://clinicaltrials.gov/study/NCT02468024"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/stable-mates-nct02468024"}